A carregar...

Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease

AIM: To assess the toxicity, tolerance, steroid-sparing capacity, effectiveness, and response rate to imatinib and dasatinib for the treatment of severe sclerotic chronic graft-vs-host disease (scGVHD). METHODS: This retrospective study analyzed 8 consecutive patients with severe refractory scGVHD w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Croat Med J
Main Authors: Sánchez-Ortega, Isabel, Parody, Rocío, Servitje, Octavio, Muniesa, Cristina, Arnan, Montserrat, Patińo, Beatriz, Sureda, Anna, Duarte, Rafael F.
Formato: Artigo
Idioma:Inglês
Publicado em: Croatian Medical Schools 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4937227/
https://ncbi.nlm.nih.gov/pubmed/27374826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3325/cmj.2016.57.247
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!